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Na1/H1 exchange and H-K ATPase increase distal tubule acidification
in chronic alkalosis. We examined whether H1-ATPase, H1-K1-ATPase,
and or Na1/H1 exchange mediates increased distal tubule acidification in
animals with chronic metabolic alkalosis using pharmacological inhibitors
of these H1 transporters in in vivo-perfused tubules of anesthetized rats.
Chronic metabolic alkalosis was induced with furosemide followed by
minimum electrolyte diet and HCO3 drinking water. The reduction in net
HCO3 reabsorption was greater in distal tubules of alkalotic compared to
control animals perfused with Schering 28080 to inhibit H1-K1-ATPase
(26.4 6 0.9 vs. 21.4 6 0.5 pmol/mm z min21, P , 0.02) and with EIPA to
inhibit Na1/H1 exchange (211.1 6 1.7 vs. 26.6 6 0.9 pmol/mm z min21,
P , 0.01) but was similar in distal tubules of alkalotic and control animals
perfused with bafilomycin to inhibit H1-ATPase. The greater reduction of
distal tubule net HCO3 reabsorption in alkalotic compared to control
animals induced by EIPA was eliminated by systemic infusion of the
endothelin receptor antagonist bosentan (24.6 6 0.7 vs. 24.4 6 0.7
pmol/mm z min21, P 5 NS) but the greater reduction induced by Schering
28080 persisted. Urine endothelin-1 (ET-1) excretion was higher in
animals with maintained alkalosis (164.5 6 23.7 vs. 76.6 6 10.8 fmol/day,
P , 0.03), but decreased following KCl repletion to a value (86.7 6 10.0
fmol/day, P , 0.02 vs. respective before-KCl value) that was not different
from that for KCl-repleted control animals (79.9 6 8.7 fmol/day, P 5 NS
vs. KCl-repleted alkalotic animals). The data support that augmented
distal tubule acidification in alkalotic animals is due to increased H1-K1-
ATPase and Na1/H1 exchange activity, the latter stimulated by endoge-
nous endothelins.
Chronic metabolic alkalosis is maintained in part by increased
distal tubule acidification [1, 2] due to augmented proton (H1)
secretion in this nephron segment [3, 4], but the H1 transporters
that meditate this increment in distal tubule acidification are not
known. At least three H1 transporters contribute to luminal H1
secretion in the rat distal nephron segment accessible to mi-
cropuncture. Vacuolar H1-ATPase mediates H1 secretion in this
segment of control rats [5] and its activity is increased by dietary
acid [6, 7]. H1-K1-ATPase contributes little to rat distal tubule
H1 secretion in controls [5] but does so significantly in those with
K1-depletion [5, 8], an etiologically important factor in some
models of chronic alkalosis [9]. Na1/H1 exchange also mediates
distal tubule luminal H1 secretion in controls [5] but the factors
that modulate this process are less well described. Nonetheless,
endothelin-1 increases Na1/H1 exchange activity renal epithelia
in vitro [10], systemic infusion increases distal tubule acidification
in vivo [11], and endogenous endothelins mediate increased distal
tubule acidification induced by dietary acid [12].
The present studies investigated relative contributions of vacu-
olar H1-ATPase, H1-K1-ATPase, and Na1/H1 exchange to
increased distal tubule acidification in rats with chronic metabolic
alkalosis. These in vivo microperfusion studies show that pharma-
cological inhibitors of Na1/H1 exchange and of H1-K1-ATPase
reduce the increment in distal tubule acidification between alka-
lotic and control animals but an H1-ATPase inhibitor did not.
Furthermore, the increment in distal tubule acidification in alka-
lotic animals sensitive to inhibition of Na1/H1 exchange was
eliminated by endothelin receptor inhibition. The data support
that increased distal tubule acidification in alkalotic animals is due
to increased H1-K1-ATPase and of Na1/H1 exchange activity,
the latter stimulated by endogenous endothelins.
METHODS
Male and female Munich-Wistar rats (Harlan Sprague-Dawley,
Houston, TX, USA) weighing 230 to 267 g and eating a minimum
electrolyte diet (ICN Nutritional Biochemicals, Cleveland, OH,
USA) were studied. Distal tubule net HCO3 reabsorption was
measured using in vivo microperfusion in controls and animals
with chronic metabolic alkalosis induced as described previously
[1]. Briefly, all animals received three intraperitoneal injections of
furosemide (10 mg/kg/dose) in 12 hour intervals while ingesting
distilled H2O. Forty-eight hours after the first furosemide dose,
drinking solution of alkalotic animals was changed to 40 mM
NaHCO3 1 40 mM KHCO3 and that of control animals to 40 mM
NaCl 1 KCl. Animals continued the low electrolyte diet and were
studied four to five weeks after protocol initiation. Because
endothelin-1 (ET-1) increases distal tubule acidification [11] and
endogenous endothelins mediate augmented distal tubule acidi-
fication [12], some animals received the endothelinA and endo-
thelinB receptor antagonist, Bosentan [13] (Hoffman-LaRoche,
Basel, Switzerland) 10 mg/kg i.v. 90 minutes before micropuncture
to explore an endothelin role in the augmented distal tubule
acidification of chronic metabolic alkalosis. This bosentan dose
inhibits initial depressor and sustained pressor responses to
ET-1 . 60% for at least six hours [13].
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Micropuncture protocol
Animals were prepared for micropuncture as previously de-
scribed [1]. A minimum of four distal tubule segments were
identified for microperfusion before using the animal for study.
This nephron segment is comprised of multiple epithelia [14],
hereafter referred to as “distal tubule” for simplicity. Tubules
were microperfused during a 90 minute period beginning 30
minutes after kidney immobilization. Perfusion and collection
pipettes were positioned in the earliest and latest (before tubule
branching) portions, respectively, of accessible distal tubules.
Perfusions were done at 6 nl/min, the early distal flow rate
measured in free-flow studies [2], calibrated in vitro and verified in
vivo using the product of collected flow rate and the collected-to-
perfusate inulin ratio. Only experiments in which these two flow
rates were between 5 to 7 nl/min and within 10% of each other
were accepted. Paired perfusions done with and without H1
transport inhibitors determined relative contributions of specific
H1 transporters to distal tubule net HCO3 reabsorption. Because
the one solution of the perfusion pair containing the H1 transport
inhibitor was always perfused last, paired perfusions were done
with identical solutions without H1 transport inhibitors as time
controls. An injected latex cast determined perfused tubule length
after acid digestion of the kidney [1]. Arterial blood (0.35 ml) was
obtained anaerobically before micropuncture and plasma ana-
lyzed for tCO2 using microcalorimetry [1] or flow-through flu-
orometry [15] as described below and for pH, PCO2, and electro-
lytes as described previously [1]. Stellate vessel blood was
obtained [16] for total CO2 (tCO2) measurement as done previ-
ously [3]. Diet, but not drinking solution, was withheld the evening
before studying micropunctured animals, yielding higher baseline
HCO3 reabsorption [17] and permitting differences in HCO3
reabsorption to be more clearly seen.
Table 1 shows that baseline perfusate [HCO3] was 7.5 mM,
providing distal tubule HCO3 delivery that was comparable to that
for alkalotic animals when perfused at 6 nl/min [2]. The perfusate
was Cl2-free to minimize HCO3 secretion and thereby permit
more focused study of H1 secretion [3]. Bafilomycin (1027 M) was
added to one solution of a perfusion pair to inhibit H1 ATPase in
this nephron segment with high specificity [18] to determine the
contribution of this H1 transporter to distal tubule net HCO3
reabsorption. Schering compound 28080 (Sch 28080) was added
(1025 M) to inhibit H1-K1-ATPase [8] and determine its contri-
bution to distal tubule net HCO3 reabsorption [5]. Sch 28080
decreases H1-ATPase activity in turtle urinary bladders when
applied at doses higher than those used in the present studies [19],
but does not affect H1-ATPase activity in rat cortical collecting
ducts [8]. Ethyl-isopropylamiloride (EIPA) at 1025 M assessed the
contribution of Na1/H1 exchange to HCO3 reabsorption in this
segment [5]. The parent compound amiloride inhibits rat cortical
collecting tubule H1-ATPase activity in vitro when added at doses
higher than those used in the present studies, but does not inhibit
H1-ATPase activity at doses comparable to those used in the
present studies [20]. Finally, amiloride does not affect rat cortical
collecting duct H1-K1-ATPase activity even at high doses [21].
Analytical methods
Immediately after the experiment termination, samples of
initial and collected perfusate as well as stellate vessel plasma
were analyzed for inulin as done previously [3]. tCO2 was mea-
sured using microcalorimetry [3] in samples from alkalotic and
control animals not given bosentan, and flow-through ultraflu-
orometry [22] was used in bosentan-treated alkalotic and control
animals. For each tCO2 measuring system, determinations were
done on the experimental day by comparing peak area of a 7 to 8
nl sample aliquot (corrected for that of a distilled H2O blank run
concomitantly with each sample group) to that of a standard
constructed for each sample run using an identical volume of the
following NaHCO3 standards: 0, 2.5, 5, 10, 25, and 50 mM. A 5 mM
NaHCO3 standard sample run five consecutive times yielded
4.9 6 0.2 mM with microcalorimetry and 5.1 6 0.1 with ultraflu-
orometry. Urine ET-1 excretion was determined in a 24 hour
collection on day 28 of the induction protocol for alkalotic and
control animals. Urine [ET-1] was measured with a RIA kit
(Peninsula Laboratories, Inc., Belmont, CA, USA) after dispos-
able column extraction (Sep-Pak C18, Milford, MA, USA) pre-
conditioned with methanol, H2O, and acetic acid as described [23]
and done in this laboratory [12]. In vitro ET-1 recoveries for rat
urine spiked with [125I]-ET-1 (ICM Biomedicals, Irvine, CA,
USA) was 71 6 2%. Because aldosterone increases rat cortical
collecting duct H1-ATPase activity [7] and thereby might mediate
augmented distal tubule acidification in alkalotic animals, plasma
aldosterone levels were measured four weeks after beginning
respective protocols in each of four alkalotic and control animals
by radioimmunoassay (COAT-A-COUNT®; DPC, Los Angeles,
CA, USA). Bafilomycin A1 was obtained from WAKO Chemicals
(Richmond, VA, USA) and Sch 28080 from Schering Plough
(Kenilworth, NJ, USA). All other compounds were from Sigma
Chemicals (St. Louis, MO, USA).
Calculations
Net HCO3 transport was the difference between perfused and
collected rates, recognizing that a small amount of HCO3 secre-
tion occurs even with Cl2-free perfusates [3]. The decrease in net
HCO3 reabsorption induced by a H
1 transport inhibitor was
compared between alkalotic and control animals to compare the
contribution of the inhibited transporter to distal tubule acidifi-
cation between groups. Each inhibitor was assumed to be specific
for the intended transporter, recognizing that specificity might
be , 100% as discussed.
Statistical analysis
One distal tubule was perfused successfully for each perturba-
tion per animal so that “N” represents both one tubule and one
animal. The Bonferroni method was used for t-test comparison of
means (P , 0.05) when multiple different comparisons of the
same parameter were done between control and alkalotic animals.
Table 1. Perfusate composition
Standard Bafilomycin Sch 28080 EIPA
Na1 61 mM 61 mM 61 mM 61 mM
K2 4 mM 4 mM 4 mM 4 mM
Cl2 0 mM 0 mM 0 mM 0 mM
HCO3 7.5 mM 7.5 mM 7.5 mM 7.5 mM
Gluconate 60 mM 60 mM 60 mM 60 mM
Raffinose 200 mM 200 mM 200 mM 200 mM
Inhibitor None 1027 M 1025 M 1025 M
All solutions contained 0.5% FD&C green dye and were bubbled with
6.7% CO2.
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RESULTS
Plasma composition
Table 2 compares plasma electrolyte and acid-base composition
between groups. Alkalotic animals had higher tCO2 in both
systemic and stellate vessel plasma and higher pH in systemic
arterial plasma. By contrast, alkalotic animals had lower values for
plasma [K1] and [Cl2].
Micropuncture data
Tables 3 to 6 show that distal tubule net HCO3 reabsorption in
did not change between paired perfusions in time controls of any
group. Table 3 shows that bafilomycin and EIPA decreased net
HCO3 reabsorption in distal tubules of control animals but net
HCO3 reabsorption was not different in distal tubules perfused
with Sch 28080. By contrast, Table 4 shows that bafilomycin, Sch
28080, and EIPA all decreased net HCO3 reabsorption in distal
tubules of alkalotic animals. Similarly, Table 5 shows that bafilo-
mycin and EIPA but not Sch 28080 decreased distal tubule net
HCO3 reabsorption in bosentan-treated control animals and
Table 6 shows that all three H1 transport inhibitors decreased net
HCO3 reabsorption in distal tubules of bosentan-treated alkalotic
animals.
Figure 1 shows the change in distal tubule HCO3 reabsorption
between the second and first perfusions of the perfusion pairs in
animals not given bosentan. The change in net HCO3 reabsorp-
tion between the second and first perfusion in all time controls
was not different from zero in all groups. By contrast, the change
in distal tubule HCO3 reabsorption was significantly less than zero
and significantly less than its respective time control in alkalotic
and control animals perfused with bafilomycin and EIPA and in
alkalotic animals perfused with Sch 28080. The decrease in HCO3
reabsorption was greater in distal tubules of alkalotic compared to
control animals perfused with Sch 28080 (26.4 6 0.9 vs. 21.4 6
0.5 pmol/mm z min21, P , 0.02) and EIPA (211.1 6 1.7 vs.
26.6 6 0.9 pmol/mm z min21, P , 0.01), but the decrease in
HCO3 reabsorption was similar in distal tubules of alkalotic and
control animals perfused with bafilomycin (26.3 6 1.0 vs. 24.2 6
0.7 pmol/mm z min21, P 5 NS). Identical comparisons for
bosentan-treated alkalotic and control animals are depicted in
Figure 2. As was seen in animals not given bosentan, the decrease
in HCO3 reabsorption was greater in distal tubules of bosentan-
treated alkalotic compared to control animals perfused with Sch
28080 (26.1 6 0.9 vs. 21.8 6 0.7 pmol/mm z min21, P , 0.02) and
was similar in alkalotic and control animals perfused with bafilo-
mycin (23.3 6 0.6 vs. 23.9 6 0.6 pmol/mm z min21, P 5 NS). In
contrast to the animals not given bosentan, Figure 2 shows that
the decrease in HCO3 reabsorption was similar in distal tubules of
bosentan-treated alkalotic and control animals perfused with
EIPA (24.6 6 0.7 vs. 24.4 6 0.7 pmol/mm z min21, P 5 NS).
Urine endothelin excretion
The bosentan data showing amelioration of augmented EIPA-
sensitive distal tubule acidification in alkalotic animals by this
Table 2. Plasma composition of micropunctured animals
Na1 K1 Cl2
tCO2,
Stellate
tCO2
Systemic
pH
PCO2
mm HgmEq/liter mM
Control (n 5 10)
146 6 2 4.1 6 0.3 111 6 2 32.1 6 1.4 24.4 6 1.5 7.39 6 0.02 40.2 6 1.7
Alkalosis (n 5 10)
148 6 2 2.9 6 0.2a 103 6 2a 37.5 6 1.6a 31.8 6 1.9a 7.46 6 0.02a 43.9 6 2.1
Values are means 6 SE; N 5 number of animals. Determinations were from arterial plasma except for stellate vessel total CO2 (tCO2).
a P , 0.05 vs. control
Table 3. HCO3 reabsorption by distal tubules of control animals pair-perfused with solution #1 without and with the indicated H
1 transport
inhibitor
Perfusate
Tubule
length, mm
Flow rate nl/min
tCO2 mM
PD mV
Net HCO3
reabsorption
pmol/mm z min21Perfusion JV Initial Collected
Log mean
gradient
Time control (N 5 5)
Standard 1.07 6 0.3 6.3 6 0.4 20.07 6 0.05 7.7 6 0.4 5.1 6 0.5 25.7 6 1.5 215.1 6 1.4 14.8 6 1.6
Standard 6.2 6 0.3 20.01 6 0.04 7.4 6 0.4 4.8 6 0.4 26.0 6 1.5 215.2 6 1.5 15.1 6 1.5
Bafilomycin, 1027 M (N 5 5)
Standard 1.09 6 0.05 6.4 6 0.5 20.05 6 0.04 7.8 6 0.5 5.3 6 0.4 25.5 6 1.5 215.5 6 1.5 14.5 6 1.3
Bafilomycin 6.3 6 0.4 20.03 6 0.02 7.6 6 0.5 5.8 6 0.4 25.4 6 1.4 216.2 6 1.5 10.3 6 0.9a
SCH 28080, 1025 M (N 5 5)
Standard 1.07 6 0.05 6.2 6 0.4 20.08 6 0.05 7.7 6 0.5 5.0 6 0.5 25.7 6 1.4 216.0 6 1.4 15.0 6 1.4
SCH 28080 6.3 6 0.4 20.03 6 0.04 7.8 6 0.5 5.5 6 0.2 25.4 6 1.4 215.1 6 1.5 13.6 6 1.4
EIPA, 1025 M (N 5 5)
Standard 1.03 6 0.04 6.2 6 0.5 20.02 6 0.04 7.6 6 0.5 5.2 6 0.5 25.7 6 1.3 216.7 6 1.5 14.6 6 1.3
EIPA 6.1 6 0.4 20.05 6 0.03 7.7 6 0.6 6.3 6 0.5a 25.1 6 1.3 214.5 6 1.3 8.0 6 0.9a,b
Values are means 6 SE; number designation refers to perfusing solution from Table 1; paired perfusing solution contained the indicated H1 transport
inhibitor; N 5 number of animals.
a P , 0.05 vs. the respective baseline (solution #1) perfusion, paired t
b P , 0.05 vs. time control group
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endothelin receptor antagonist are consistent with an endothelin
role in mediating increased distal tubule acidification in alkalotic
animals. Because K1 repletion corrects augmented distal tubule
acidification in alkalotic animals [9], plasma tCO2 concentration
and urine ET-1 excretion were measured in four each of alkalotic
and control animals before and 24 hours after beginning 80 mM
KCl drinking solution. Alkalotic and control animals had respec-
tive tail vein plasma tCO2 concentrations of 32.9 6 1.9 and 25.1 6
1.5 mM four weeks into their respective induction protocols and
were 26.7 6 1.7 and 24.8 6 1.5 mM, respectively, 24 hours
following initiation of the KCl drinking solution. Figure 3 shows
that urine ET-1 excretion was higher in alkalotic compared to
control animals before KCl (164.5 6 23.7 vs. 76.6 6 10.8 fmol/day,
P , 0.03) but decreased following KCl repletion in alkalotic
animals to a value (86.7 6 10.0 fmol/day, P , 0.02 vs. respective
before-KCl value) not different from that for KCl-repleted con-
trol animals (79.9 6 8.7 fmol/day, P 5 NS vs. KCl-repleted
alkalotic animals).
Plasma aldosterone levels
Plasma aldosterone concentration was lower in alkalotic com-
pared to control animals (1.5 6 0.2 vs. 3.8 6 0.4 ng/dl, P , 0.002).
DISCUSSION
The kidney helps to maintain some types of chronic metabolic
alkalosis by excreting acid despite extracellular fluid alkalosis [1].
In vivo microperfusion studies in rats with chronic metabolic
alkalosis show that increased distal tubule acidification [1, 2]
mediated by increased H1 secretion [3, 4] contributes to urine
acid excretion in this metabolic disorder. Furthermore, K1 deple-
tion in some models of chronic metabolic alkalosis [1, 9] contrib-
utes to the augmented distal tubule acidification in these animals
by mechanisms that remain poorly understood. The present
studies show that inhibitors of H1-K1-ATPase and of Na1/H1
exchange reduce the increment distal nephron acidification be-
tween alkalotic and control animals, but an H1-ATPase inhibitor
Table 4. HCO3 reabsorption by distal tubules of animals with chronic metabolic alkalosis pair-perfused with solution #1 without and with the
indicated H1 transport inhibitor
Perfusate
Tubule length,
mm
Flow rate nl/min
tCO2 mM
PD
mV
Net HCO3
reabsorption
pmol/mm z min21Perfusion JV Initial Collected
Log mean
gradient
Time control (N 5 4)
Standard 1.11 6 0.05 6.4 6 0.5 20.08 6 0.04 7.6 6 0.6 3.1 6 0.3 32.1 6 1.8 220.2 6 1.9 25.5 6 1.6
Standard 6.5 6 0.4 20.03 6 0.01 7.7 6 0.6 3.4 6 0.3 31.9 6 1.8 218.9 6 1.9 25.0 6 1.9
Bafilomycin, 1027 M (N 5 5)
Standard 1.15 6 0.06 6.1 6 0.4 20.03 6 0.04 7.6 6 0.6 2.9 6 0.3 32.1 6 1.9 218.5 6 1.7 26.1 6 1.9
Bafilomycin 6.3 6 0.3 0.01 6 0.02 7.6 6 0.5 4.0 6 0.4a 31.7 6 1.9 219.6 6 1.9 19.8 6 1.8a
SCH 28080, 1025 M (N 5 5)
Standard 1.12 6 0.04 6.2 6 0.5 20.07 6 0.05 7.8 6 0.5 3.3 6 0.3 31.9 6 1.9 220.6 6 2.0 24.9 6 1.5
SCH 28080 6.3 6 0.4 20.01 6 0.03 7.5 6 0.5 4.2 6 0.5a 31.6 6 1.8 218.9 6 1.9 18.5 6 1.8a
EIPA, 1025 M (N 5 5)
Standard 1.17 6 0.04 6.1 6 0.4 20.02 6 0.03 7.7 6 0.5 2.9 6 0.3 32.1 6 1.8 219.8 6 1.8 25.2 6 1.3
EIPA 6.1 6 0.4 0.03 6 0.02 7.9 6 0.6 5.2 6 0.5a 30.9 6 1.7 219.5 6 1.8 14.1 6 1.2a,b
Values are means 6 SE; number designation refers to perfusing solution from Table 1; paired perfusing solution contained the indicated H1 transport
inhibitor; N 5 number of animals.
a P , 0.05 vs. the respective baseline (solution #1) perfusion, paired t
b P , 0.05 vs. time control group
Table 5. Bicarbonate reabsorption by distal tubules of bosentan-treated control animals pair-perfused with solution #1 without and with the
indicated H1 transport inhibitor
Perfusate
Tubule length,
mm
Flow rate nl/min
tCO2 mM
PD
mV
Net HCO3
reabsorption
pmol/mm z min21Perfusion JV Initial Collected
log mean
gradient
Time control (N 5 4)
Standard 1.18 6 0.06 6.1 6 0.2 20.03 6 0.01 7.6 6 0.3 4.9 6 0.2 26.2 6 1.4 215.2 6 1.4 13.8 6 1.2
Standard 6.0 6 0.2 0.02 6 0.01 7.8 6 0.3 5.3 6 0.3 25.9 6 1.4 213.9 6 1.2 12.7 6 1.2
Bafilomycin, 1027 M (N 5 5)
Standard 1.13 6 0.06 6.0 6 0.1 0.02 6 0.04 7.8 6 0.4 5.4 6 0.3 25.9 6 1.3 214.6 6 1.4 13.1 6 1.2
Bafilomycin 6.0 6 0.2 0.01 6 0.03 7.8 6 0.3 6.1 6 0.3a 25.5 6 1.3 215.6 6 1.4 9.2 6 1.0a
SCH 28080, 1025 M (N 5 5)
Standard 1.14 6 0.05 6.1 6 0.2 0.02 6 0.03 7.8 6 0.4 5.4 6 0.4 25.9 6 1.3 216.8 6 1.5 12.7 6 1.1
SCH 28080 6.1 6 0.2 20.02 6 0.01 7.7 6 0.3 5.6 6 0.5a 25.8 6 1.3 216.2 6 1.6 10.9 6 1.0
EIPA, 1025 M (N 5 5)
Standard 1.12 6 0.05 6.0 6 0.1 20.01 6 0.02 7.9 6 0.5 5.3 6 0.2 25.9 6 1.4 214.5 6 1.5 13.7 6 1.4
EIPA 6.1 6 0.1 20.02 6 0.03 7.6 6 0.6 6.0 6 0.5a 25.7 6 1.4 213.6 6 1.5 9.3 6 0.9a
Values are means 6 SE; number designation refers to perfusing solution from Table 1; paired perfusing solution contained the indicated H1 transport
inhibitor; N 5 number of animals.
a P , 0.05 vs. the respective baseline (solution #1) perfusion, paired t
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does not. Furthermore, endothelin receptor inhibition eliminates
the increment in distal tubule acidification mediated by Na1/H1
exchange, consistent with an endothelin role in mediating aug-
mented acidification. The data support that augmented distal
tubule acidification in animals with chronic metabolic alkalosis is
mediated by increased H1-K1-ATPase and increased Na1/H1
exchange activity, the latter stimulated by endogenous endothe-
lins.
Clarification of the mechanisms by which chronic metabolic
alkalosis is maintained has been hampered by attempts to recon-
cile data from studies using different experimental preparations,
techniques, and models of this metabolic disorder [1]. The present
in vivo studies have the advantage of permitting tubule mecha-
nisms to be assessed in situ but pose the challenge of defining the
environmental factors that induce the altered tubule function.
Second, pharmacologic inhibition of H1 transporters as done in
the present studies allows in vivo assessment of acidification in a
fashion that minimally disturbs overall tubule function, but the
conclusions reached regarding the components of tubule acidifi-
cation are valid only to the extent that the inhibitors used are
specific for the transporters they are purported to inhibit. Never-
theless, specificity of the inhibitors used at the doses employed in
the present studies appear sufficient to support the stated conclu-
sions, as discussed in the Methods section. Third, data discussed
apply to the present model and possibly to others with similar
characteristics but extrapolating these findings to other models
should be done with caution. The present model is K1 and Cl2
deplete, excretes an acid urine, and has augmented acidification in
both proximal and distal tubules [1]. Augmented distal tubule
acidification in this model is mediated by increased H1 secretion
[3, 4], which is normalized by KCl but not by NaCl repletion [9].
It follows that K1 depletion, which is associated with stimu-
lated distal tubule HCO3 reabsorption [24], contributes impor-
tantly to increased distal tubule acidification in this model.
Fig. 1. Change in distal tubule net HCO3 reabsorption between the last
and first perfusions of perfusion pairs in animals not given bosentan.
Abbreviations are: Baf, bafilomycin (1027 M); Sch, Schering 28080 (1025
M); and EIPA, ethyl-isopropylamiloride (1025 M). Data are means 6 SE.
*P , 0.05 versus respective time control. 1P , 0.05 versus respective
control group. Symbols are: (M) controls; (o) alkalosis.
Fig. 2. Change in distal tubule net HCO3 reabsorption between the last
and first perfusions of perfusion pairs in animals given bosentan.
Abbreviations are: Baf, bafilomycin (1027 M); Sch, Schering 28080 (1025
M); and EIPA, ethyl-isopropylamiloride (1025 M). Data are means 6 SE.
*P , 0.05 versus respective time control. 1P , 0.05 versus respective
control group. Symbols are: (M) control; (o) alkalosis.
Table 6. Bicarbonate reabsorption by distal tubules of bosentan-treated animals with chronic metabolic alkalosis pair-perfused with solution #1
without and with the indicated H1 transport inhibitor
Perfusate
Tubule length,
mm
Flow rate, nl/min
tCO2, mM
PD
mV
Net HCO3
reabsorption
pmol/mm z min21Perfusion JV Initial Collected
log mean
gradient
Time control (N 5 4)
Standard 1.20 6 0.07 5.9 6 0.1 20.01 6 0.02 7.7 6 0.3 3.9 6 0.2 31.7 6 1.5 219.0 6 1.9 18.8 6 1.5
Standard 6.0 6 0.1 20.03 6 0.01 7.9 6 0.3 4.5 6 0.3 31.3 6 1.5 218.4 6 1.9 17.0 6 1.4
Bafilomycin, 1027 M (N 5 5)
Standard 1.16 6 0.07 6.1 6 0.1 20.03 6 0.02 7.7 6 0.3 4.5 6 0.3 31.4 6 1.5 221.5 6 1.9 17.1 6 1.9
Bafilomycin 6.0 6 0.1 20.01 6 0.04 7.8 6 0.4 5.1 6 0.4a 31.0 6 1.4 219.9 6 2.0 13.8 6 1.2a
SCH 28080, 1025 M (N 5 5)
Standard 1.15 6 0.05 6.0 6 0.2 20.03 6 0.04 7.6 6 0.3 4.4 6 0.2 31.5 6 1.5 220.1 6 2.1 16.7 6 1.4
SCH 28080 5.9 6 0.1 0.02 6 0.03 7.6 6 0.2 5.6 6 0.3a 30.9 6 1.5 219.7 6 1.9 10.6 6 1.0a
EIPA, 1025 M (N 5 5)
Standard 1.19 6 0.05 6.1 6 0.1 0.01 6 0.04 7.6 6 0.3 4.1 6 0.2 31.6 6 1.5 222.0 6 2.1 17.9 6 1.4
EIPA 5.9 6 0.1 0.02 6 0.01 7.7 6 0.3 5.0 6 0.3a 31.1 6 1.5 220.8 6 1.9 13.3 6 1.2a
Values are means 6 SE; number designation refers to perfusing solution from Table 1; paired perfusing solution contained the indicated H1 transport
inhibitor; N 5 number of animals.
a P , 0.05 vs. the respective baseline (solution #1) perfusion, paired t
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Therefore, these findings more likely apply to models of
chronic metabolic alkalosis with K1 depletion and less likely to
those without it.
The present studies show that Sch 28080 decreases distal tubule
net HCO3 reabsorption in alkalotic but not control animals,
supporting the hypothesis that increased H1-K1-ATPase activity
contributes to the augmented distal tubule acidification in alka-
lotic animals. This H1-K1-ATPase inhibitor has little effect on
distal tubule acidification in control rats [5] but K1 depletion
induces expression of a Sch 28080-sensitive H1-K1-ATPase in the
rat cortical collecting tubule [25], an epithelium comprising the rat
distal tubule accessible to micropuncture [14]. K1 depletion is a
component of the chronic alkalosis model used in the present
studies [1] and K1 repletion restores augmented distal tubule
acidification to a level comparable to control [9]. Although high
Sch 28080 concentrations inhibit H1-ATPase activity in turtle
bladders in vitro [19], even high concentrations do not affect
activity of this transporter in the rat cortical collecting duct [8].
Furthermore, bafilomycin, a more specific H1-ATPase inhibitor
[18], clearly inhibits distal tubule acidification in both alkalotic
and control animals whereas the effect of Sch 28080 was
demonstrable in only alkalotic animals. Thus, the present
studies clearly distinguish the effects of these two H1 transport
inhibitors and support that part of the augmented distal tubule
acidification in alkalotic animals is mediated by the described
H1-K1-ATPase.
The rat cortical collecting tubule has H1-ATPase activity [7]
and this transporter contributes to in vivo distal tubule acidifica-
tion in control animals [5]. The H1-ATPase inhibitor bafilomycin
decreased distal tubule acidification to a similar degree in alka-
lotic and control animals, supporting that activity of this trans-
porter is not increased in the present model of chronic metabolic
alkalosis. Systemic factors shown to increase cortical collecting
tubule H1-ATPase activity include acid-loading [6, 7], aldoste-
rone [7], and angiotensin II [26]. The alkalotic animals of the
present studies were not acid-loaded and their plasma aldosterone
level was low, possibly due to K1 depletion [27] in this model of
chronic alkalosis [1]. Lower plasma aldosterone might yield low
H1-ATPase activity [7] rather than the level comparable to
control shown in the present studies. Whether some other phe-
nomena also stimulates this transporter, counterbalancing the
effect of low aldosterone levels, or whether the effect of aldoste-
rone on this transporter differs in the present experimental model
is unclear. Unpublished studies in our laboratory show that i.v.
infusion of the angiotensin converting enzyme inhibitor captopril
causes hypotension in the alkalotic animals, precluding distal
tubule perfusion. The data are consistent with increased angio-
tensin II activity in the alkalotic animals, but whether this agent
contributes to augmented acidification in this model of chronic
alkalosis could not be determined.
Na1/H1 exchange contributes to distal tubule acidification [5]
and the larger EIPA-sensitive component of acidification in
alkalotic animals suggests that increased Na1/H1 exchange me-
diates a portion of the augmented acidification in alkalotic
animals. EIPA reduced distal tubule net HCO3 reabsorption
without affecting tubule voltage as previously shown for hexa-
methylene-amiloride [28]. The absence of an effect on tubule
voltage reflects high specificity of these compounds for Na1/H1
exchange and low specificity for the Na1 channel [29]. The
present studies are consistent with a role for endogenous endo-
thelins as mediators of augmented EIPA-sensitive distal tubule
acidification in the alkalotic animals. Endothelin-1 (ET-1) in-
creases Na1/H1 exchange in renal epithelia in vitro [10], increases
distal tubule acidification when infused systemically [11], and
endogenous endothelins mediate increased distal tubule acidifi-
cation induced by dietary acid [12]. The present studies show that
the high urine ET-1 excretion in animals with maintained alkalosis
decreases to a level comparable to control (as did plasma tCO2)
after KCl repletion. Previous studies from this laboratory show
that KCl repletion normalizes augmented H1 secretion in the
distal tubule of this model of chronic metabolic alkalosis [9]. The
present studies support a model in which K1 depletion, a key
determinant of chronic metabolic alkalosis, increases renal endo-
thelin production which in turn increases distal tubule acidifica-
tion. Confirmation of this hypothetical model awaits further
studies.
In summary, the present studies show that inhibitors of H1-
K1-ATPase and of Na1/H1 exchange reduce the increment in
distal tubule acidification between alkalotic and control animals
but an H1-ATPase inhibitor does not. Endothelin receptor inhi-
bition eliminated the increment in distal tubule acidification in
alkalotic animals sensitive to inhibition of Na1/H1 exchange.
Furthermore, the data show increased urine ET-1 excretion in
animals with maintained alkalosis that was reduced to a level
comparable to that in control animals in response to KCl reple-
tion. The data support that increased distal tubule acidification in
alkalotic animals is mediated by increased H1-K1-ATPase and
increased Na1/H1 exchange activity, the latter stimulated by
endogenous endothelins.
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alkalosis.
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